Table 4.
Sarcopenia prevalence (%) according to EWGSOP1 and 2 at selected cut-offs
| Sarcopenia criteria | Sarcopenia prevalence (%) | ||||||
|---|---|---|---|---|---|---|---|
| EWGSOP (cut-offs)a | 70-year-olds | 85-year-olds | |||||
| Men | Women | Both sexes | Men | Women | Both sexes | All | |
| EWGSOP 1 (T-score − 2.0) | 5.1 | 9.9b | 7.8 | 56 | 65 | 62 | 16 |
| EWGSOP 2 (T-score − 2.0) | 3.8 | 9.5b | 7.0 | 54 | 63 | 60 | 15 |
| EWGSOP 1 (T-score − 2.5) | 1.8 | 2.0 | 1.9 | 33 | 51b | 45 | 8.4 |
| EWGSOP 2 (T-score − 2.5) | 1.0 | 1.6 | 1.4 | 33 | 47 | 42 | 7.5 |
| EWGSOP 1 (original)a | 4.6 | 1.8b | 3.1 | 61 | 50 | 54 | 11 |
| EWGSOP 2 (original)a | 3.6 | 2.2 | 2.8 | 53 | 54 | 54 | 10 |
| EWGSOP 1 or 2, severe (T-score − 2.0) | 0.5 | 1.8 | 1.2 | 25 | 35 | 31 | 5.8 |
| EWGSOP 1 or 2, severe (T-score − 2.5) | 0.3 | 0.2 | 0.2 | 12 | 23 | 19 | 3.1 |
| EWGSOP 1, severe (original)a | 0 | 0 | 0 | 3.5 | 6.0 | 5.1 | 0.8 |
| EWGSOP 2, severe (original)a | 0 | 0 | 0 | 3.5 | 6.0 | 5.1 | 0.8 |
EWGSOP; The European Working Groupon Sarcopenia in Older People 2010 (EWGSOP1) [1] and 2019 (EWGSOP2) [2] diagnostic criteria (Table 1 and Table 3)
a Cut-offs as published by the EWGSOP 1 and 2 (original) [1, 2] and population based T-scores (−2.0 and − 2.5) (Table 3)
b Difference between sexes within age cohort (P < 0.05)